In conclusion, this study revealed that the regrowth of MYCN-amplified tumours post-COJEC is influenced by the infiltration of macrophages to the TME, and inhibiting macrophage recruitment can be a viable follow-up treatment option for post-treatment relapse in high-risk NB (Figure 7). The gene discussed is MYCN; the disease is neoplasm.